Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusiness

Suven Life gets patents from Europe, South Korea

"We are pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS arena, which are being developed for cognitive disorders with high unmet medical need with a huge market potential globally," Suven Life CEO Venkat Jasti said.

July 16, 2018 / 12:38 PM IST
Mangalam Organics has gained 1324 percent in the last 5 years. As of June 10, 2015, the share price was Rs 23.15 per share and now the current share price is Rs 329.75 with a market cap of Rs 282 crore.

Mangalam Organics has gained 1324 percent in the last 5 years. As of June 10, 2015, the share price was Rs 23.15 per share and now the current share price is Rs 329.75 with a market cap of Rs 282 crore.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Suven Life Sciences today said it has been granted a product patent by Europe and South Korea each for a new chemical entity (NCE) used in treatment of disorders associated with neurodegenerative diseases.

These patents are valid through 2033 and 2034, respectively, the company said in a BSE filing.

"We are pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS arena, which are being developed for cognitive disorders with high unmet medical need with a huge market potential globally," Suven Life CEO Venkat Jasti said.

The granted claims of patents are being developed as therapeutic agents useful in treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, attention deficient hyperactivity disorder (ADHD), Huntington's disease, Parkinson's and schizophrenia, it added.

Shares of Suven Life Sciences were trading 0.55 per cent down at Rs 216.05 on BSE.

PTI
first published: Jul 16, 2018 12:32 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347